Stephen Guy

1 POSTS 0 COMMENTS
Stephen Guy trained as a physicist and has been responsible for delivering a suite of innovative products to market significantly enhancing the quality and efficiency of life science research. He has worked on the development of novel sensors, consumables and instruments and has held senior engineering and management roles at Renishaw plc, Oxford Instruments plc, and TAP Biosystems Ltd (now a Sartorius Stedim Biotech company). He is presently a Principal Consultant for Design Momentum Ltd, and is working in partnership with Plextek to develop new products in the fields of sample management and collaborative robotics.

Latest articles

Moderna jab marks new milestone in NHS vaccination programme

Moderna jab marks new milestone in NHS vaccination programme

A third COVID-19 vaccine has started being rolled out across more than 20 sites, including Reading’s Madejski Stadium and the Sheffield Arena, as the...
Antibiotic Research UK launches small research grants programme

Antibiotic Research UK launches small research grants programme

Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, has just launched its largest grants programme to date, the 2021 Small...
First AI-designed Immuno-oncology drug to enter clinical trials

First AI-designed Immuno-Oncology drug to enter clinical trials

Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New COVID-19 test reduces testing time from 30 minutes to five

New COVID-19 test reduces testing time from 30 minutes to five

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
Image of a number of blocks and levels with different icons including magnifying glass, target, steps and graphs to show Coronavirus clinical research brought together in free information centre

Understanding the role of the MSL

Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription